<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H1431653C1965492F91691AE3C6211156" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>118 HR 3471 IH: Access to Safe Contraception Act of 2023</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2023-05-18</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">118th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 3471</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20230518">May 18, 2023</action-date><action-desc><sponsor name-id="B000740">Mrs. Bice</sponsor> (for herself, <cosponsor name-id="K000397">Mrs. Kim of California</cosponsor>, <cosponsor name-id="S001199">Mr. Smucker</cosponsor>, <cosponsor name-id="B001298">Mr. Bacon</cosponsor>, <cosponsor name-id="M001215">Mrs. Miller-Meeks</cosponsor>, and <cosponsor name-id="G000577">Mr. Graves of Louisiana</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To preempt States from establishing, implementing, or enforcing any ban on the prescription, provision, or use of a drug, biological product, or device for contraception if such drug, biological product, or device is approved, licensed, cleared, or otherwise authorized for human use by the Food and Drug Administration for contraception, and for other purposes.</official-title></form><legis-body id="H0763E3EDDE4749D786A771480F9AAAC1" style="OLC"><section id="H7FDB0D6190B642DBAEB6C9384D6F7F7B" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Access to Safe Contraception Act of 2023</short-title></quote>.</text></section><section id="HA83DC3D97BB744158E76742576E31BA0"><enum>2.</enum><header>Preemption of State bans on FDA-approved products for contraception</header><subsection id="H9F5C4D608D3F4D0991CF5459ED44BC6C"><enum>(a)</enum><header>Preemption</header><text display-inline="yes-display-inline">No State shall establish, implement, or enforce any ban on the prescription, provision, or use of a drug, biological product, or device for contraception if such drug, biological product, or device is approved, licensed, cleared, or otherwise authorized for human use by the Food and Drug Administration for contraception.</text></subsection><subsection id="H67C10D2393E04BD2A30CCA6C155DDD27"><enum>(b)</enum><header>Rules of construction</header><text>Nothing in subsection (a) shall be construed—</text><paragraph id="H92AA23699AB742CF9327C073763ADBC0"><enum>(1)</enum><text>to infringe the ability of a State to regulate the practice of medicine and pharmacy within such State;</text></paragraph><paragraph id="HD907D285315E4BF1A214E4E4A3DB952D"><enum>(2)</enum><text>to preempt the Religious Freedom Restoration Act of 1993 (<external-xref legal-doc="usc" parsable-cite="usc/42/2000bb">42 U.S.C. 2000bb et seq.</external-xref>); or</text></paragraph><paragraph id="HDAC466932D9A4A909CAC1E066BB156F7"><enum>(3)</enum><text display-inline="yes-display-inline">to preempt any State law to the extent such State law protects the right of any entity to opt out of providing contraception if such provision would be contrary to that entity’s religious or moral beliefs.</text></paragraph></subsection><subsection id="HBC863C00C75F4D1894E64164431A9874"><enum>(c)</enum><header>Definitions</header><text display-inline="yes-display-inline">In this section:</text><paragraph id="H19C8077A901C4540BC9E0D9B70E143E5"><enum>(1)</enum><text>The term <term>biological product</term> has the meaning given such term in section 351 of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/262">42 U.S.C. 262</external-xref>).</text></paragraph><paragraph id="H5E14D48024EF4735A4D6601E1A14EDCA"><enum>(2)</enum><text>The terms <term>device</term> and <term>drug</term> have the meanings given such terms in section 201 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/321">21 U.S.C. 321</external-xref>).</text></paragraph></subsection></section></legis-body></bill> 

